COLUMBIA, Md., Sept. 08, 2016 (GLOBE NEWSWIRE) -- WellDoc, a digital health technology leader, today announced planned participation among its leadership team members at several upcoming conferences and industry events in the months ahead. Following is a list of events with information on WellDoc presentations.
22nd Annual Medical Design & Manufacturing (MD&M) Minneapolis
September 21 – 22, 2016, Minneapolis Convention Center, Minneapolis, MN
WellDoc Chief Strategy Officer Anand K. Iyer, PhD, MBA, will present a keynote speech titled, “Evidence-Based Requirements for mHealth Products,” on September 22, 2016 at 10:00 am.
Murer Annual Healthcare Seminar
September 22 – 23, 2016, Olympia Fields Country Club, Olympia Fields, IL
Dr. Iyer will discuss how disruptive technology in chronic disease models is changing the face of healthcare systems and associated business models at 11:00 am on September 23, 2016.
Patient Centered Medical Home (PCMH) Congress
October 7 – 9, Chicago Hilton, Chicago, IL
WellDoc Vice President of Clinical Advocacy Malinda Peeples, RN, MS, CDE, along with research partners, Janet Duni, RN, BSN, Director of Care Coordination at Vanguard Medical Group, and Edwin Fisher, PhD, Global Director for Peers for Progress, will present “Patient Engagement and Digital Health: Opportunities for Care Coordinators and Chronic Disease Management,” at 9:20 am on October 7, 2016. The presenters will highlight opportunities to integrate mHealth into regular disease management and care for patients with chronic diseases.
Food and Nutrition Conference and Exhibition (FNCE) 2016
October 15 – 18, 2016, Boston Convention and Exhibition Center, Boston, MA
WellDoc Director, Clinical Innovation, Janice MacLeod, MA, RDN, LDN, CDE, and WellDoc Manager, Content Development, Catherine Brown, MS, RDN, CDE, will present their work with Marion Franz, MS, RD, CDE, a nutrition and health consultant with Nutrition Concept by Franz, on “Evidence Based Diabetes Nutrition Therapy Practice Guidelines: Effectiveness and Recommendations,” to the American Association of Nutrition and Dietetics for the Evidence Analysis Library (EAL) at 8:00 am on October 17, 2016.
About WellDoc®
WellDoc is a digital health technology company that develops mobile solutions to drive behavioral and clinical change in chronic disease. WellDoc’s goal is to improve patient self-management and help physicians overcome gaps in the delivery system to improve clinical outcomes and decrease cost. WellDoc has commercialized BlueStar®, a digital therapeutic, for adults with type 2 diabetes. This therapeutic is designed to fill the support gap between patients and providers during the 8700 hours that individuals live their lives outside the healthcare system each year. WellDoc has a proven track record of contributing published, peer-reviewed clinical evidence since 2008 and presented real-world patient engagement and clinical outcomes at the American Diabetes Association’s (ADA) 76th Scientific Sessions. BlueStar® is recognized by the ADA on its website as the first and only in the new class of diabetes treatment known as Mobile Prescription Therapy. In a recently published Forbes blog, WellDoc was named among one of five healthcare tech companies to watch in 2016. For more information, visit www.WellDoc.com and www.BlueStarDiabetes.com.